These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 9157193

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Halistanol disulfate B, a novel sulfated sterol from the sponge Pachastrella sp.: inhibitor of endothelin converting enzyme.
    Patil AD, Freyer AJ, Breen A, Carte B, Johnson RK.
    J Nat Prod; 1996 Jun; 59(6):606-8. PubMed ID: 8786367
    [Abstract] [Full Text] [Related]

  • 3. Role of Protein Kinase C in Endothelin Converting Enzyme-1 trafficking and shedding from endothelial cells.
    Kuruppu S, Tochon-Danguy N, Smith AI.
    Biochem Biophys Res Commun; 2010 Jul 23; 398(2):173-7. PubMed ID: 20558134
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of lysoPAF acetyltransferase activity by components of licorice root.
    Nagumo S, Fukuju A, Takayama M, Nagai M, Yanoshita R, Samejima Y.
    Biol Pharm Bull; 1999 Oct 23; 22(10):1144-6. PubMed ID: 10549875
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Novel selective quinazoline inhibitors of endothelin converting enzyme-1.
    Ahn K, Sisneros AM, Herman SB, Pan SM, Hupe D, Lee C, Nikam S, Cheng XM, Doherty AM, Schroeder RL, Haleen SJ, Kaw S, Emoto N, Yanagisawa M.
    Biochem Biophys Res Commun; 1998 Feb 04; 243(1):184-90. PubMed ID: 9473502
    [Abstract] [Full Text] [Related]

  • 8. Design and synthesis of diversely substituted azacyclic inhibitors of endothelin converting enzyme.
    Hanessian S, Gauchet C, Charron G, Marin J, Nakache P.
    J Org Chem; 2006 Mar 31; 71(7):2760-78. PubMed ID: 16555831
    [Abstract] [Full Text] [Related]

  • 9. TMC-66, a new endothelin converting enzyme inhibitor produced by Streptomyces sp. A5008.
    Asai Y, Nonaka N, Suzuki S, Nishio M, Takahashi K, Shima H, Ohmori K, Ohnuki T, Komatsubara S.
    J Antibiot (Tokyo); 1999 Jul 31; 52(7):607-12. PubMed ID: 10513839
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors.
    Firooznia F, Gude C, Chan K, Fink CA, Qiao Y, Satoh Y, Marcopoulos N, Savage P, Beil ME, Bruseo CW, Trapani AJ, Jeng AY.
    Bioorg Med Chem Lett; 2001 Feb 12; 11(3):375-8. PubMed ID: 11212114
    [Abstract] [Full Text] [Related]

  • 11. Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1.
    Fink CA, Moskal M, Firooznia F, Hoyer D, Symonsbergen D, Wei D, Qiao Y, Savage P, Beil ME, Trapani AJ, Jeng AY.
    Bioorg Med Chem Lett; 2000 Sep 04; 10(17):2037-9. PubMed ID: 10987444
    [Abstract] [Full Text] [Related]

  • 12. Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme.
    Wallace EM, Moliterni JA, Moskal MA, Neubert AD, Marcopulos N, Stamford LB, Trapani AJ, Savage P, Chou M, Jeng AY.
    J Med Chem; 1998 Apr 23; 41(9):1513-23. PubMed ID: 9554884
    [Abstract] [Full Text] [Related]

  • 13. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
    Kukkola PJ, Savage P, Sakane Y, Berry JC, Bilci NA, Ghai RD, Jeng AY.
    J Cardiovasc Pharmacol; 1995 Apr 23; 26 Suppl 3():S65-8. PubMed ID: 8587470
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of novel substituted pyridines as inhibitors of endothelin converting enzyme-1 (ECE-1).
    Massa MA, Patt WC, Ahn K, Sisneros AM, Herman SB, Doherty A.
    Bioorg Med Chem Lett; 1998 Aug 18; 8(16):2117-22. PubMed ID: 9873497
    [Abstract] [Full Text] [Related]

  • 15. Differential inhibition of wild-type endothelin-converting enzyme-1 and its mutants.
    Savage P, De Lombaert S, Shimada K, Tanzawa K, Jeng AY.
    J Cardiovasc Pharmacol; 1998 Aug 18; 31 Suppl 1():S16-8. PubMed ID: 9595388
    [Abstract] [Full Text] [Related]

  • 16. Utility of endothelin-converting enzyme inhibitors for the treatment of cardiovascular diseases.
    Jeng AY.
    Curr Opin Investig Drugs; 2003 Sep 18; 4(9):1076-81. PubMed ID: 14582451
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of tyrosinase activity by polyphenol compounds from Flemingia philippinensis roots.
    Wang Y, Curtis-Long MJ, Lee BW, Yuk HJ, Kim DW, Tan XF, Park KH.
    Bioorg Med Chem; 2014 Feb 01; 22(3):1115-20. PubMed ID: 24412339
    [Abstract] [Full Text] [Related]

  • 18. Targeting ACE and ECE with dual acting inhibitors.
    Hanessian S, Guesné S, Riber L, Marin J, Benoist A, Mennecier P, Rupin A, Verbeuren TJ, De Nanteuil G.
    Bioorg Med Chem Lett; 2008 Feb 01; 18(3):1058-62. PubMed ID: 18160283
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of endothelin-converting enzyme inhibitors using cultured cells.
    Corder R.
    Methods Mol Biol; 2002 Feb 01; 206():147-64. PubMed ID: 12152225
    [No Abstract] [Full Text] [Related]

  • 20. [Synthesis and hemodynamic effects of the new inhibitor of endothelin converting enzyme].
    Pozdnev VF, Gomazkov OA, Davydova MP, Medvedeva NA.
    Biull Eksp Biol Med; 1998 Nov 01; 126(11):526-9. PubMed ID: 9883360
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.